Results for tag: "Dronabinol"

Dronabinol is a synthetic form of tetrahydrocannabinol (THC), the active ingredient in cannabis. It is used to treat nausea and vomiting caused by chemotherapy in cancer patients. It is also used to treat anorexia associated with weight loss in people with AIDS. Dronabinol is available in capsule form and is taken orally. It is also available as a liquid solution for oral administration. Dronabinol is a Schedule III controlled substance in the United States, meaning it has a moderate potential for abuse and dependence. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of chemotherapy-induced nausea and vomiting and AIDS-related anorexia. In the oncology drugs market, dronabinol is used to treat nausea and vomiting caused by chemotherapy and to stimulate appetite in people with AIDS. It is also used to treat pain and spasticity associated with multiple sclerosis. Some companies in the dronabinol market include AbbVie, Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., and Insys Therapeutics, Inc. Show Less Read more